BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 36317527)

  • 1. Alcohol intake and cardiovascular disease and mortality: the role of pre-existing disease.
    Friesema IH; Zwietering PJ; Veenstra MY; Knottnerus JA; Garretsen HF; Lemmens PH
    J Epidemiol Community Health; 2007 May; 61(5):441-6. PubMed ID: 17435212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcohol intake and mortality risk of COVID-19, pneumonia, and other infectious diseases: An analysis of 437191 UK biobank participants.
    Huang BH; Inan-Eroglu E; Shaban RZ; Hamer M; Britton A; Stamatakis E
    Prev Med Rep; 2022 Apr; 26():101751. PubMed ID: 35251915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver disease is a significant risk factor for cardiovascular outcomes - A UK Biobank study.
    He C; Lu D; Zheng S; Xu X
    J Hepatol; 2024 Jun; 80(6):e287-e288. PubMed ID: 38097115
    [No Abstract]   [Full Text] [Related]  

  • 4. The relationship between alcohol use and long-term cognitive decline in middle and late life: a longitudinal analysis using UK Biobank.
    Piumatti G; Moore SC; Berridge DM; Sarkar C; Gallacher J
    J Public Health (Oxf); 2018 Jun; 40(2):304-311. PubMed ID: 29325150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excessive Alcohol Use and Alcohol Use Disorders: A Policy Brief of the American College of Physicians.
    Crowley R; Hilden D; Beachy M;
    Ann Intern Med; 2024 May; 177(5):656-657. PubMed ID: 38648644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between alcohol use and long-term cognitive decline in middle and late life: a longitudinal analysis using UK Biobank.
    Piumatti G; Moore S; Berridge D; Sarkar C; Gallacher J
    J Public Health (Oxf); 2018 Jun; 40(2):313-314. PubMed ID: 29462350
    [No Abstract]   [Full Text] [Related]  

  • 7. Validating the new nomenclature of steatotic liver disease in patients with excessive alcohol intake.
    Wu Y; Fang F
    Lancet Gastroenterol Hepatol; 2024 May; 9(5):409. PubMed ID: 38604196
    [No Abstract]   [Full Text] [Related]  

  • 8. Delivering health care education and information about excessive alcohol consumption and risks of alcohol-associated liver disease.
    Damjanovska S; Karb DB; Cohen SM
    Clin Liver Dis (Hoboken); 2023 Nov; 22(5):184-187. PubMed ID: 38026117
    [No Abstract]   [Full Text] [Related]  

  • 9. High 10-year mortality in alcohol-related liver disease: where do we go from here?
    Mellinger JL
    Lancet Gastroenterol Hepatol; 2023 Nov; 8(11):961-962. PubMed ID: 37660705
    [No Abstract]   [Full Text] [Related]  

  • 10. A polygenic risk score for alcohol-associated cirrhosis among heavy drinkers with European ancestry.
    Schwantes-An TH; Whitfield JB; Aithal GP; Atkinson SR; Bataller R; Botwin G; Chalasani NP; Cordell HJ; Daly AK; Darlay R; Day CP; Eyer F; Foroud T; Gawrieh S; Gleeson D; Goldman D; Haber PS; Jacquet JM; Lammert CS; Liang T; Liangpunsakul S; Masson S; Mathurin P; Moirand R; McQuillin A; Moreno C; Morgan MY; Mueller S; Müllhaupt B; Nagy LE; Nahon P; Nalpas B; Naveau S; Perney P; Pirmohamed M; Seitz HK; Soyka M; Stickel F; Thompson A; Thursz MR; Trépo E; Morgan TR; Seth D;
    Hepatol Commun; 2024 Jun; 8(6):. PubMed ID: 38727677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling the roles of excessive alcohol use and liver disease in mortality.
    Mitchell MC; Cotter TG
    Alcohol Clin Exp Res (Hoboken); 2023 Mar; 47(3):429-431. PubMed ID: 36585252
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of work-based screening for early signs of alcohol-related liver disease in hazardous and harmful drinkers: the PrevAIL study.
    Cook PA; Morleo M; Billington D; Sanderson-Shortt K; Jones C; Gabbay M; Sheron N; Bellis MA; Phillips-Howard PA; Gilmore IT
    BMC Public Health; 2015 Jun; 15():532. PubMed ID: 26041363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Problem drinking, wellbeing and mortality risk in Chinese men: findings from the China Kadoorie Biobank.
    Im PK; Millwood IY; Chen Y; Guo Y; Du H; Kartsonaki C; Bian Z; Tan Y; Su J; Li Y; Yu C; Lv J; Li L; Yang L; Chen Z;
    Addiction; 2020 May; 115(5):850-862. PubMed ID: 31692116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol, drinking pattern and all-cause, cardiovascular and alcohol-related mortality in Eastern Europe.
    Bobak M; Malyutina S; Horvat P; Pajak A; Tamosiunas A; Kubinova R; Simonova G; Topor-Madry R; Peasey A; Pikhart H; Marmot MG
    Eur J Epidemiol; 2016 Jan; 31(1):21-30. PubMed ID: 26467937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality in relation to consumption of alcohol: 13 years' observations on male British doctors.
    Doll R; Peto R; Hall E; Wheatley K; Gray R
    BMJ; 1994 Oct; 309(6959):911-8. PubMed ID: 7950661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. All-cause and liver-related mortality risk factors in excessive drinkers: Analysis of data from the UK biobank.
    Whitfield JB; Seth D; Morgan TR;
    Alcohol Clin Exp Res; 2022 Dec; 46(12):2245-2257. PubMed ID: 36317527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Coffee Drinking With Mortality by Genetic Variation in Caffeine Metabolism: Findings From the UK Biobank.
    Loftfield E; Cornelis MC; Caporaso N; Yu K; Sinha R; Freedman N
    JAMA Intern Med; 2018 Aug; 178(8):1086-1097. PubMed ID: 29971434
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.